The data indicates a robust and consistent efficacy, making GLP-1 agonists a preferred option for both clinicians and patients in the ongoing pursuit of better health outcomes
However, the major concern with BPC 157 is the lack of substantial evidence confirming its safety in humans
Major factors that are expected to boost the market's growth during the forecast period are rising obesity and inactivity rates among people, which have resulted in an increase in the diabetes population over time, a rise in the sedentary lifestyle, improper dietary patterns, and the inherent history of diabetes disorders
Drugs Exp Clin Res 16 : 101106 Ghiglieri O, Gambarana C, Scheggi S, Tagliamonte A, Willner P, De Montis MG
Per milligram costs vary by supplier and vial size, but expect to pay less than growth hormone secretagogues and more than basic amino acid compounds